Pijnappel, Esther N. http://orcid.org/0000-0002-4998-9732
Dijksterhuis, Willemieke P. M.
Sprangers, Mirjam A. G.
Augustinus, Simone
de Vos-Geelen, Judith
de Hingh, Ignace H. J. T.
Molenaar, Izaak Q.
Busch, Olivier R.
Besselink, Marc G.
Wilmink, Johanna W.
van Laarhoven, Hanneke W. M.
,
Article History
Received: 28 October 2021
Accepted: 28 January 2022
First Online: 15 February 2022
Declarations
:
: According to the Central Committee on Research involving Human Subjects, this type of study does not require approval from an ethics committee in the Netherlands.
: Not applicable.
: Not applicable.
: JdVG has served as a consultant for Amgen, AstraZeneca, MSD, Pierre Fabre, and Servier and has received institutional research funding from Servier. All outside the submitted work. IHJTdH has received research funding from Roche and RanD Biotech, paid to the institute. JWW has served as a consultant for Shire, Servier, and Celgene and reports grants from Servier, Halozyne, Novartis, Celgene, Astra Zeneca, Pfizer, Roche, and Amgen and Merck. HWMvL reports a consult/advisory role for BMS, Celgene, Lilly, Merck, Nordic, and Servier and has received unrestricted research funding from Bayer, BMS, Celgene, Lilly, Merck Serono, MSD, Nordic, Philips, Roche, and Servier. The other authors declare that they have no conflicts of interest.